New Research Highlights Benicar Complications
There are few things more concerning than being prescribed medication that is supposed to help you and learning that you may be at risk for devastating side effects.
That is the situation that thousands of Benicarusers find themselves in. Benicar, a popular medication used to treat high blood pressure, has raised serious concerns. The drug has caused patients to experience severe gastrointestinal problems, including:
- Rapid weight loss
- Chronic diarrhea
Benicar is produced by Japanese drugmaker Daiichi Sankyo and has been on the market since 2002. The drug belongs to a class of blood pressure medication called angiotensin receptor blockers. This class of blood pressure medicines are especially concerning because their side effects mimic other diseases and cause doctors to misdiagnose patients.
When it is unclear that Benicar is the actual cause of patient’s side effects patients may be forced to continue using the drug and thereby exacerbate their symptoms. Benicar causes patients to experience symptoms which resemble Celiac Disease. The drug causes many patients to develop a condition called sprue-like enteropathy.
Sprue-like enteropathy was first recognized in a study conducted by the Mayo Clinic in 2012. In response, the U.S. Food and Drug Administration (FDA) began to conduct its own studies. In July 2013, the FDA issued an alert confirming that the use of blood pressure medications such as Benicar were clearly linked to the development of sprue-like enteropathy.
As the evidence against Benicar continues to mount, injured patients and their families have begun to file Benicar lawsuits in U.S. courts. The patients have allegedly developed sprue-like enteropathy.
How Can Peterson & Associates, P.C. Help Me?
The skilled nationwide defective drug lawyers at Peterson & Assocites will evaluate your case and determine how you and your family can get the financial compensation you deserve. By acting quickly, you can launch your legal claim today.